On April 28, a federal appeals court upheld the lower court’s ruling to block industry giant Anthem’s proposed acquisition of Cigna. This is a monumental win for America’s patients and physicians, which was made possible through medicine’s leadership — most notably the American Medical Association.
“These insurance companies were trying to stack the deck,” said AMA President Andrew W. Gurman, M.D. “They sought even more negotiating power over you. But, using hard data in conjunction with partners, we were able to convince the courts not to allow this to occur.”
Barring an appeal to the U.S. Supreme Court, this decision concludes a successful campaign by the AMA and 17 state medical societies, including key efforts from the FMA to protect you and your patients. Together, we collected the insights, analysis and facts needed to win this case, again.
“The House of Medicine sent a clear, persuasive message that Anthem’s proposal was not in the best interests of patients.”, said FMA President David J. Becker, M.D.
For 21 months, the AMA, state medical societies and other partners examined the current landscape in each state, as well as the future implications of these proposed mega-‐mergers. The AMA’s annual “Competition in Health Insurance”, an analysis of insurance markets, showed nearly half of all states could see diminished competition in local health insurance markets if the Anthem-Cigna and Aetna-Humana megamergers were allowed to proceed.
With the evidence on our side, the coalition advocated before the U.S. Department of Justice, congressional committees, state attorneys general, insurance commissioners and federal courts, and this outcome illustrates that when the House of Medicine joins together, the best outcome for patients can be achieved.